Myriad Genetics Inc (MYGN)

EBITDA Growth

91.75%

Quarterly · Period ending:

MYGN logo

MYGN EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported91.75%
MYGN Quarterly EBITDA YoY % (-420.00% → 91.75%)
High-resolution chart · PNG

MYGN ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Myriad Genetics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
5.342%
-2.4841%
-44.0998%
-30.1193%
-13.0606%
-15.7447%
38.4615%
30.7692%
20.6897%
28.2265%
-13.0435%
-36.8421%
-1,550%
18.1818%
37.8378%
40.625%
108%
-43.4783%
-131.25%
-420%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.